SIRT1 and diabetic retinopathy: Chronic treatment of SRT1720, an isoform-selective SIRT1 activator, has been reported to alleviate diabetic retinopathy by preventing cholesterol accumulation, inflammation, visual dysfunction, vascular degeneration, and neuro-degeneration in the retina of T2D mice [262].